List of Excipients in API GLYCOPYRROLATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing GLYCOPYRROLATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merz Pharmaceuticals LLC | CUVPOSA | glycopyrrolate | 0259-0501 | CITRIC ACID MONOHYDRATE | |
| Merz Pharmaceuticals LLC | CUVPOSA | glycopyrrolate | 0259-0501 | GLYCERIN | |
| Merz Pharmaceuticals LLC | CUVPOSA | glycopyrrolate | 0259-0501 | METHYLPARABEN | |
| Merz Pharmaceuticals LLC | CUVPOSA | glycopyrrolate | 0259-0501 | PROPYLENE GLYCOL | |
| Merz Pharmaceuticals LLC | CUVPOSA | glycopyrrolate | 0259-0501 | PROPYLPARABEN | |
| Merz Pharmaceuticals LLC | CUVPOSA | glycopyrrolate | 0259-0501 | SACCHARIN SODIUM | |
| Merz Pharmaceuticals LLC | CUVPOSA | glycopyrrolate | 0259-0501 | SODIUM CITRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing GLYCOPYRROLATE
Detailed excipient profiles for GLYCOPYRROLATE
Excipient focus: 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
GLYCOPYRROLATE drug variants containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | glycopyrrolate and formoterol fumarate | 0310-4600 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
GLYCOPYRROLATE drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
GLYCOPYRROLATE drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: ANHYDROUS LACTOSE
GLYCOPYRROLATE drug variants containing ANHYDROUS LACTOSE
GLYCOPYRROLATE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BENZYL ALCOHOL
GLYCOPYRROLATE drug variants containing BENZYL ALCOHOL
GLYCOPYRROLATE drug variants not containing BENZYL ALCOHOL
Excipient focus: CALCIUM CHLORIDE
GLYCOPYRROLATE drug variants containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | glycopyrrolate and formoterol fumarate | 0310-4600 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing CALCIUM CHLORIDE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
GLYCOPYRROLATE drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| Alembic Labs LLC | glycopyrrolate | 15955-305 |
| Rising Pharmaceuticals Inc | glycopyrrolate | 64980-258 |
| Carilion Materials Management | glycopyrrolate | 68151-0614 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
GLYCOPYRROLATE drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
GLYCOPYRROLATE drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
Excipient focus: CALCIUM PYROPHOSPHATE
GLYCOPYRROLATE drug variants containing CALCIUM PYROPHOSPHATE
GLYCOPYRROLATE drug variants not containing CALCIUM PYROPHOSPHATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
GLYCOPYRROLATE drug variants containing CELLULOSE, MICROCRYSTALLINE
GLYCOPYRROLATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
GLYCOPYRROLATE drug variants containing CITRIC ACID MONOHYDRATE
GLYCOPYRROLATE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: COPOVIDONE K25-31
GLYCOPYRROLATE drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Labs LLC | glycopyrrolate | 15955-305 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing COPOVIDONE K25-31
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
GLYCOPYRROLATE drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
GLYCOPYRROLATE drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: GLYCERIN
GLYCOPYRROLATE drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Camber Pharmaceuticals Inc | glycopyrrolate | 31722-016 |
| NorthStar RxLLC | glycopyrrolate | 72603-240 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing GLYCERIN
Excipient focus: HYDROCHLORIC ACID
GLYCOPYRROLATE drug variants containing HYDROCHLORIC ACID
GLYCOPYRROLATE drug variants not containing HYDROCHLORIC ACID
Excipient focus: LACTOSE
GLYCOPYRROLATE drug variants containing LACTOSE
GLYCOPYRROLATE drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
GLYCOPYRROLATE drug variants containing LACTOSE MONOHYDRATE
GLYCOPYRROLATE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
GLYCOPYRROLATE drug variants containing MAGNESIUM STEARATE
GLYCOPYRROLATE drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHYLPARABEN
GLYCOPYRROLATE drug variants containing METHYLPARABEN
GLYCOPYRROLATE drug variants not containing METHYLPARABEN
Excipient focus: NORFLURANE
GLYCOPYRROLATE drug variants containing NORFLURANE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | glycopyrrolate and formoterol fumarate | 0310-4600 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing NORFLURANE
Excipient focus: POVIDONE
GLYCOPYRROLATE drug variants containing POVIDONE
GLYCOPYRROLATE drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
GLYCOPYRROLATE drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| West-ward Pharmaceutical Corp | glycopyrrolate | 0143-1250 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing POVIDONE K30
Excipient focus: POVIDONES
GLYCOPYRROLATE drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Par Formulations Private Limited | glycopyrrolate | 43227-065 |
| Nuro Pharma Inc | glycopyrrolate | 59547-210 |
| Bryant Ranch Prepack | glycopyrrolate | 63629-5442 |
| Rising Pharmaceuticals Inc | glycopyrrolate | 64980-272 |
| Carilion Materials Management | glycopyrrolate | 68151-0614 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing POVIDONES
Excipient focus: PROPYLENE GLYCOL
GLYCOPYRROLATE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Camber Pharmaceuticals Inc | glycopyrrolate | 31722-016 |
| NorthStar RxLLC | glycopyrrolate | 72603-240 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
GLYCOPYRROLATE drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Camber Pharmaceuticals Inc | glycopyrrolate | 31722-016 |
| NorthStar RxLLC | glycopyrrolate | 72603-240 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing PROPYLPARABEN
Excipient focus: SACCHARIN SODIUM
GLYCOPYRROLATE drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Camber Pharmaceuticals Inc | glycopyrrolate | 31722-016 |
| NorthStar RxLLC | glycopyrrolate | 72603-240 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing SACCHARIN SODIUM
Excipient focus: SODIUM CHLORIDE
GLYCOPYRROLATE drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Exela Pharma Sciences LLC | glycopyrrolate | 51754-6015 |
| Holopack Verpackungstechnik GmbH | glycopyrrolate | 60940-024 |
| Sunovion Pharmaceuticals Inc | glycopyrrolate | 63402-201 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM CITRATE
GLYCOPYRROLATE drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
GLYCOPYRROLATE drug variants containing SODIUM HYDROXIDE
GLYCOPYRROLATE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
GLYCOPYRROLATE drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Intra-Sana Laboratories | glycopyrrolate | 80056-160 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
GLYCOPYRROLATE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
GLYCOPYRROLATE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SORBITOL
GLYCOPYRROLATE drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0501 |
| Merz Pharmaceuticals LLC | glycopyrrolate | 0259-0502 |
| Camber Pharmaceuticals Inc | glycopyrrolate | 31722-016 |
| NorthStar RxLLC | glycopyrrolate | 72603-240 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing SORBITOL
Excipient focus: STARCH, CORN
GLYCOPYRROLATE drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Stason Pharmaceuticals Inc | glycopyrrolate | 60763-475 |
| Bryant Ranch Prepack | glycopyrrolate | 71335-1225 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
GLYCOPYRROLATE drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | glycopyrrolate | 60429-665 |
| Quinn Pharmaceuticals | glycopyrrolate | 69076-475 |
| REMEDYREPACK INC | glycopyrrolate | 70518-3152 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: TRISODIUM CITRATE DIHYDRATE
GLYCOPYRROLATE drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | glycopyrrolate | 31722-016 |
| NorthStar RxLLC | glycopyrrolate | 72603-240 |
| >Company | >Ingredient | >NDC |
GLYCOPYRROLATE drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
GLYCOPYRROLATE drug variants containing WATER
GLYCOPYRROLATE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
